Position
Squarepoint Ops LLC in Biomarin Pharmaceutical Inc
Back to the book · All holders of BMRN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.06M$59.43 → $56.49
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.83M | $108.7M | — | — | — | 0.1% |
| Q1 2026 | 359.7K | $20.3M | $56.49 | −$1.06M | −$87.3M | 0.0% |